A Prospective Study to Evaluate the Efficacy of Iovera Lumbar Medial Branch Cryoneurolysis Versus Radiofrequency Ablation for the Treatment of Chronic Low Back Pain

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMontefiore Medical Center

About this trial

A research study is being conducted to compare two treatments for long-term low back pain:

* One uses the iovera° system, which applies cold to certain nerves in the lower back. * The other is the standard treatment called radiofrequency ablation, which uses heat.

The primary objective is to find out which treatment works better to reduce back pain. Participants in this study will be randomly placed in one of the two treatment groups. The clinical research team will check on participant pain levels and overall health before and after the procedure for about 12 months. The entire study will last about 14 months for each participant.

Eligibility criteria

Qualifiers

Subjects at least 18 years of age at Screening

Primary complaint of axial low-back pain suggestive of bilateral facet joint involvement (i.e., facet mediated CLBP) by evidence of provocative testing (e.g., axial loading, paraspinal tenderness)

Low back pain is chronic (i.e., ≥ 3 months' duration)

Low back pain is moderate to severe (score of ≥ 5 to ≤ 9) on the 0 to 10 NRS at Screening

Disqualifiers

Active workers' compensation, personal injury, Social Security disability insurance (SSDI), or other litigation/compensation related to the spine

Suspected cauda equina syndrome (e.g., bowel/bladder dysfunction)

Infection

Tumor

Trial design

Treatments tested in this trial

  • Iovera Medial Branch Cryoneurolysis
  • Radiofrequency ablation (RFA)

Treatment groups

110 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Montefiore Medical Center

Lead sponsor

Pacira Pharmaceuticals, Inc

Collaborator